These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34658678)

  • 1. Corporate dividend policy in the time of COVID-19: Evidence from the G-12 countries.
    Ali H
    Financ Res Lett; 2022 May; 46():102493. PubMed ID: 34658678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the COVID-19 pandemic on dividends.
    Krieger K; Mauck N; Pruitt SW
    Financ Res Lett; 2021 Oct; 42():101910. PubMed ID: 34566530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are owners chalk and cheese in the context of dividend smoothing asymmetry?
    Ali Z; Hanming Y; Zhongxin W; Ali S
    Front Psychol; 2022; 13():969782. PubMed ID: 36329747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Behavioral Foundations and Business Strategy on Corporate Dividend Policy.
    Liao WJ; Lin YE; Li XZ; Chih HH
    Front Psychol; 2022; 13():849238. PubMed ID: 35401304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corporate going-concern report in early pandemic situation: Evidence from Indonesia.
    Fidiana F; Yani P; Suryaningrum DH
    Heliyon; 2023 Apr; 9(4):e15138. PubMed ID: 37089310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dividend policy and crisis: Exploring the interplay between performance and financial constraints in the French context.
    Theiri S; Ben Hamad S; Ben Amor M
    Heliyon; 2023 Oct; 9(10):e20586. PubMed ID: 37842631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of corporate social responsibility performance on dividend pay-out: Role of corporate governance quality.
    Maqbool Z; Abid A; Bhutta AI
    Front Psychol; 2022; 13():883952. PubMed ID: 36003105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dividend policy issues in the European pharmaceutical industry: new empirical evidence.
    Basse T; Schwarzbach C; Graf von der Schulenburg JM
    Eur J Health Econ; 2023 Jul; 24(5):803-816. PubMed ID: 36018442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volatility of Tax Payments and Dividend Payouts.
    Amberger HJ
    Contemp Account Res; 2023; 40(1):451-487. PubMed ID: 38528965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corporate payout, cash holdings, and the COVID-19 crisis: Evidence from the G-7 countries.
    Ntantamis C; Zhou J
    Financ Res Lett; 2022 Dec; 50():103275. PubMed ID: 36034341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious diseases, dividend policy, and independent directors: Evidence from textual analysis.
    Ungpakorn S; Chatjuthamard P; Jiraporn P; Phiromswad P
    PLoS One; 2023; 18(2):e0281109. PubMed ID: 36730357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Covid-19 outbreak, corporate financial distress and earnings management.
    Aljughaiman AA; Nguyen TH; Trinh VQ; Du A
    Int Rev Financ Anal; 2023 Jul; 88():102675. PubMed ID: 37144179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic: Evidence from the U.S. restaurant industry.
    Song HJ; Yeon J; Lee S
    Int J Hosp Manag; 2021 Jan; 92():102702. PubMed ID: 33024347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Impact of Supply Chain Relationship Strategy on Corporate Cash Dividend Policy Based on Chinese Data.
    Yang X; Sun L
    Front Public Health; 2022; 10():902648. PubMed ID: 35707057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does corporate governance affect financial analysts' stock recommendations, target prices accuracy and earnings forecast characteristics? An empirical investigation of US companies.
    Bouteska A; Mili M
    Empir Econ; 2022; 63(4):2125-2171. PubMed ID: 36118292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dividend suspensions and cash flows during the Covid-19 pandemic: A dynamic econometric model.
    Pettenuzzo D; Sabbatucci R; Timmermann A
    J Econom; 2023 Aug; 235(2):1522-1541. PubMed ID: 36714078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corporate social performance and firm debt levels: Impacts of the covid-19 pandemic and institutional environments.
    Bai M; Ho L
    Financ Res Lett; 2022 Jun; 47():102968. PubMed ID: 35578609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries.
    Archanskaia E; Canton E; Hobza A; Nikolov P; Simons W
    Eur Econ Rev; 2023 Jun; ():104509. PubMed ID: 37360582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of government policies for Italian firms during the COVID-19 crisis.
    Fasano F; Javier Sánchez-Vidal F; La Rocca M
    Financ Res Lett; 2022 Dec; 50():103273. PubMed ID: 36035254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Country risk, global uncertainty, and firms' cash holdings: Do the role of law, culture, and financial market development matter?
    Athari SA; Cho Teneng R; Çetinkaya B; Bahreini M
    Heliyon; 2024 Mar; 10(5):e26266. PubMed ID: 38463892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.